We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generics Seek Stronger Proscriptions In REMS Compliance Letter Guidance
Generics Seek Stronger Proscriptions In REMS Compliance Letter Guidance
Generic drugmakers charge a December draft guidance doesn’t go far enough in enabling them to obtain bioequivalence testing batches for drugs protected by REMS product safety protocols.